Percutaneous Cavernous Nerve Electro-Stimulation For Treatment Of Erectile Dysfunction
Authors: Author Two Name , Author One Name ,
Abstract
Pelvic fracture urethral injury (PFUI) is the major etiological factor of neurological erectile dysfunction (NED). We reported a patient whose Index of Erectile Function-5 (IIEF-5) score was 7 (severe ED) and experienced a failed treatment of Tadalafil. NED was the final diagnosis made by examinations such as nocturnal penile tumescence (NPT), penile cavernous contrast and three-dimensional reconstruction and the penial dorsal nerve somatosensory evoked potential. Percutaneous cavernous nerve electro-stimulation was used as treatment for NED. After three courses of treatment, the IIEF-5 score was up to 18 points and the level of erection hardness was between grade III and IV. We concluded that percutaneous cavernous nerve electro-stimulation will be a new strategy to treat patients with NED with PFUI history.
Keywords: kw1, kio9, fda,
Pubmed Style
Author Two Name, Author One Name. Percutaneous Cavernous Nerve Electro-Stimulation For Treatment Of Erectile Dysfunction. DJ. 2021; 05 (March 2021): 1-4. doi:10.67247/ILLO/1-94
Publication History
Received: March 01, 2021
Revised: March 02, 2021 Revised: March 03, 2021
Accepted: March 04, 2021
Published: March 05, 2021
Authors
Author Two Name
P O Box 230631
Author One Name
P O Box 230631